
Yipinhong Pharmaceutical Co Ltd
SZSE:300723

Income Statement
Earnings Waterfall
Yipinhong Pharmaceutical Co Ltd
Revenue
|
1.2B
CNY
|
Cost of Revenue
|
-577.5m
CNY
|
Gross Profit
|
626.9m
CNY
|
Operating Expenses
|
-1.1B
CNY
|
Operating Income
|
-426.3m
CNY
|
Other Expenses
|
-157.7m
CNY
|
Net Income
|
-584m
CNY
|
Income Statement
Yipinhong Pharmaceutical Co Ltd
Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||
Interest Expense |
4
|
15
|
0
|
0
|
0
|
17
|
7
|
0
|
9
|
5
|
13
|
14
|
13
|
12
|
8
|
11
|
18
|
39
|
40
|
47
|
0
|
24
|
29
|
26
|
0
|
38
|
52
|
53
|
57
|
35
|
39
|
|
Revenue |
1 399
N/A
|
1 380
-1%
|
1 467
+6%
|
1 477
+1%
|
1 426
-3%
|
1 430
+0%
|
1 395
-2%
|
1 435
+3%
|
1 538
+7%
|
1 637
+6%
|
1 641
+0%
|
1 515
-8%
|
1 640
+8%
|
1 675
+2%
|
1 851
+10%
|
1 978
+7%
|
2 135
+8%
|
2 199
+3%
|
2 200
+0%
|
2 151
-2%
|
2 161
+0%
|
2 280
+6%
|
2 480
+9%
|
2 641
+6%
|
2 515
-5%
|
2 503
0%
|
2 410
-4%
|
2 150
-11%
|
1 893
-12%
|
1 450
-23%
|
1 204
-17%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||
Cost of Revenue |
(631)
|
(580)
|
(622)
|
(582)
|
(465)
|
(394)
|
(336)
|
(317)
|
(341)
|
(367)
|
(370)
|
(329)
|
(352)
|
(295)
|
(340)
|
(341)
|
(360)
|
(318)
|
(333)
|
(324)
|
(308)
|
(300)
|
(380)
|
(427)
|
(468)
|
(475)
|
(565)
|
(559)
|
(580)
|
(575)
|
(577)
|
|
Gross Profit |
769
N/A
|
800
+4%
|
845
+6%
|
895
+6%
|
961
+7%
|
1 036
+8%
|
1 059
+2%
|
1 118
+6%
|
1 197
+7%
|
1 270
+6%
|
1 270
0%
|
1 187
-7%
|
1 289
+9%
|
1 380
+7%
|
1 511
+9%
|
1 637
+8%
|
1 774
+8%
|
1 881
+6%
|
1 867
-1%
|
1 828
-2%
|
1 853
+1%
|
1 980
+7%
|
2 100
+6%
|
2 213
+5%
|
2 047
-8%
|
2 029
-1%
|
1 845
-9%
|
1 592
-14%
|
1 313
-17%
|
875
-33%
|
627
-28%
|
|
Operating Income | ||||||||||||||||||||||||||||||||
Operating Expenses |
(584)
|
(603)
|
(637)
|
(691)
|
(745)
|
(808)
|
(816)
|
(854)
|
(925)
|
(1 095)
|
(1 090)
|
(1 036)
|
(1 062)
|
(1 185)
|
(1 305)
|
(1 409)
|
(1 532)
|
(1 609)
|
(1 576)
|
(1 533)
|
(1 608)
|
(1 654)
|
(1 723)
|
(1 848)
|
(1 692)
|
(1 759)
|
(1 585)
|
(1 423)
|
(1 257)
|
(1 151)
|
(1 053)
|
|
Selling, General & Administrative |
(578)
|
(519)
|
(645)
|
(676)
|
(707)
|
(717)
|
(706)
|
(760)
|
(843)
|
(996)
|
(1 010)
|
(948)
|
(1 010)
|
(1 048)
|
(1 172)
|
(1 275)
|
(1 390)
|
(1 437)
|
(1 449)
|
(1 413)
|
(1 409)
|
(1 436)
|
(1 571)
|
(1 632)
|
(1 496)
|
(1 406)
|
(1 297)
|
(1 145)
|
(962)
|
(749)
|
(746)
|
|
Research & Development |
0
|
(81)
|
0
|
(31)
|
0
|
(90)
|
(89)
|
(75)
|
(88)
|
(95)
|
(91)
|
(97)
|
(111)
|
(131)
|
(146)
|
(149)
|
(169)
|
(128)
|
(150)
|
(160)
|
(160)
|
(160)
|
(204)
|
(250)
|
(249)
|
(270)
|
(316)
|
(314)
|
(325)
|
(279)
|
(286)
|
|
Depreciation & Amortization |
0
|
(12)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(60)
|
0
|
0
|
0
|
(90)
|
0
|
0
|
0
|
(123)
|
0
|
0
|
0
|
(142)
|
0
|
|
Other Operating Expenses |
(6)
|
10
|
9
|
16
|
(38)
|
12
|
(21)
|
(20)
|
5
|
12
|
10
|
7
|
59
|
11
|
13
|
16
|
27
|
15
|
23
|
40
|
(39)
|
32
|
52
|
33
|
53
|
41
|
28
|
35
|
30
|
19
|
(20)
|
|
Operating Income |
185
N/A
|
198
+7%
|
208
+5%
|
204
-2%
|
216
+6%
|
228
+6%
|
243
+6%
|
264
+9%
|
271
+3%
|
175
-35%
|
180
+3%
|
150
-17%
|
226
+51%
|
195
-14%
|
206
+6%
|
228
+11%
|
242
+6%
|
271
+12%
|
291
+7%
|
295
+1%
|
245
-17%
|
326
+33%
|
378
+16%
|
365
-3%
|
355
-3%
|
270
-24%
|
261
-3%
|
168
-35%
|
56
-67%
|
(276)
N/A
|
(426)
-54%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||
Interest Income Expense |
(16)
|
(15)
|
(13)
|
(8)
|
(8)
|
6
|
8
|
9
|
14
|
7
|
(2)
|
(2)
|
0
|
3
|
9
|
6
|
16
|
(6)
|
3
|
(4)
|
(14)
|
(44)
|
(53)
|
(54)
|
(57)
|
(56)
|
(58)
|
(78)
|
(102)
|
(72)
|
(50)
|
|
Non-Reccuring Items |
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
(0)
|
(0)
|
(24)
|
1
|
|
Total Other Income |
18
|
4
|
(0)
|
(2)
|
(3)
|
9
|
9
|
5
|
9
|
7
|
2
|
8
|
2
|
75
|
80
|
75
|
86
|
79
|
82
|
104
|
113
|
45
|
41
|
59
|
40
|
31
|
26
|
(19)
|
(286)
|
(274)
|
(223)
|
|
Pre-Tax Income |
186
N/A
|
185
-1%
|
195
+6%
|
194
-1%
|
206
+6%
|
244
+18%
|
260
+7%
|
278
+7%
|
294
+6%
|
189
-36%
|
180
-5%
|
157
-13%
|
229
+46%
|
273
+19%
|
295
+8%
|
309
+5%
|
345
+11%
|
363
+5%
|
376
+4%
|
395
+5%
|
344
-13%
|
326
-5%
|
366
+12%
|
371
+1%
|
339
-9%
|
244
-28%
|
229
-6%
|
71
-69%
|
(332)
N/A
|
(646)
-94%
|
(697)
-8%
|
|
Net Income | ||||||||||||||||||||||||||||||||
Tax Provision |
(32)
|
(30)
|
(31)
|
(29)
|
(27)
|
(36)
|
(42)
|
(44)
|
(52)
|
(47)
|
(44)
|
(41)
|
(58)
|
(50)
|
(47)
|
(49)
|
(53)
|
(69)
|
(77)
|
(77)
|
(69)
|
(64)
|
(73)
|
(60)
|
(64)
|
(92)
|
(86)
|
(79)
|
(45)
|
79
|
89
|
|
Income from Continuing Operations |
154
|
155
|
164
|
165
|
179
|
208
|
218
|
234
|
243
|
143
|
137
|
115
|
171
|
224
|
248
|
261
|
292
|
293
|
299
|
318
|
276
|
262
|
293
|
310
|
275
|
152
|
143
|
(7)
|
(377)
|
(567)
|
(609)
|
|
Income to Minority Interest |
2
|
2
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
25
|
14
|
19
|
25
|
9
|
29
|
29
|
31
|
32
|
33
|
31
|
33
|
33
|
27
|
25
|
|
Net Income (Common) |
156
N/A
|
157
+0%
|
166
+6%
|
167
+1%
|
180
+8%
|
208
+16%
|
219
+5%
|
234
+7%
|
243
+4%
|
144
-41%
|
138
-4%
|
117
-15%
|
173
+48%
|
226
+31%
|
250
+11%
|
263
+5%
|
317
+21%
|
307
-3%
|
319
+4%
|
344
+8%
|
285
-17%
|
291
+2%
|
322
+11%
|
341
+6%
|
307
-10%
|
185
-40%
|
174
-6%
|
26
-85%
|
(344)
N/A
|
(540)
-57%
|
(584)
-8%
|
|
EPS (Diluted) |
0.72
N/A
|
0.71
-1%
|
0.57
-20%
|
0.55
-4%
|
0.63
+15%
|
0.72
+14%
|
0.74
+3%
|
0.8
+8%
|
0.83
+4%
|
0.5
-40%
|
0.48
-4%
|
0.41
-15%
|
0.6
+46%
|
0.79
+32%
|
0.86
+9%
|
0.92
+7%
|
1.1
+20%
|
0.71
-35%
|
1.11
+56%
|
1.19
+7%
|
0.66
-45%
|
0.67
+2%
|
0.74
+10%
|
0.76
+3%
|
0.63
-17%
|
0.42
-33%
|
0.39
-7%
|
0.05
-87%
|
-0.76
N/A
|
-1.2
-58%
|
-1.29
-8%
|